Semaglutide is gaining traction as a promising treatment for insulin resistance. This manufactured glucagon-like peptide-1 (GLP-1) receptor agonist functions through stimulating the pancreas to release more insulin and curbing glucagon production. , Additionally, , semaglutide displays potential applications beyond diabetes management, including w

Semaglutide has gained significant traction in recent years as a medication for treating type 2 diabetes and obesity. This powerful glucagon-like peptide-1 (GLP-1) receptor agonist works by mimicking the effects of a naturally occurring hormone in the body, promoting blood sugar control . Understanding how semaglutide functions is essential for in